Profil
Mr. Thomas G.
Mechtersheimer is a Chief Executive Officer & Executive Director at neurocare group AG and a Founder at Passion Innovation Group Pty Ltd. He is on the Board of Directors at neurocare group AG.
Mr. Mechtersheimer was previously employed as a Non-Executive Director by Fresenius Kabi Oncology Ltd. and a President-Asia Pacific Region by Fresenius Kabi AG.
Aktive Positionen von Thomas Mechtersheimer
| Unternehmen | Position | Beginn |
|---|---|---|
Passion Innovation Group Pty Ltd.
Passion Innovation Group Pty Ltd. Financial ConglomeratesFinance Provides investment services to the technology industry | Gründer | 11.12.2013 |
neurocare group AG
neurocare group AG Packaged SoftwareTechnology Services Operates as a neuromodulation therapy platform to clinical and commercial outcomes | Gründer | 01.01.2015 |
Ehemalige bekannte Positionen von Thomas Mechtersheimer
| Unternehmen | Position | Ende |
|---|---|---|
| FRESENIUS KABI ONCOLOGY LTD | Direktor/Vorstandsmitglied | - |
Fresenius Kabi AG
Fresenius Kabi AG Pharmaceuticals: MajorHealth Technology Develops and manufactures medicines for oncology & autoimmune diseases | Corporate Officer/Principal | - |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 4 |
|---|---|
Fresenius Kabi AG
Fresenius Kabi AG Pharmaceuticals: MajorHealth Technology Develops and manufactures medicines for oncology & autoimmune diseases | Health Technology |
Fresenius Kabi Oncology Ltd.
Fresenius Kabi Oncology Ltd. Miscellaneous Commercial ServicesCommercial Services Manufactures and markets cancer research and anticancer products | Commercial Services |
Passion Innovation Group Pty Ltd.
Passion Innovation Group Pty Ltd. Financial ConglomeratesFinance Provides investment services to the technology industry | Finance |
neurocare group AG
neurocare group AG Packaged SoftwareTechnology Services Operates as a neuromodulation therapy platform to clinical and commercial outcomes | Technology Services |
















